Drug Therapy of Migraine

New England Journal of Medicine

Volumn 329, Issue 20, 1993, Pages 1476-1483

  Wood, Alastair J J ^a   Welch, K M A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; BUTALBITAL; CODEINE; DANAZOL; DEXTROPROPOXYPHENE; DIHYDROERGOTAMINE; ERGOTAMINE; ESTRADIOL; HYDROXYZINE; ISOMETHEPTENE MUCATE; KETOROLAC; METHYSERGIDE; METOCLOPRAMIDE; NAPROXEN; NIFEDIPINE; NIMODIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PERPHENAZINE; PETHIDINE; PIZOTIFEN; PROPRANOLOL; SUMATRIPTAN; TAMOXIFEN; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL;

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; DRUG MECHANISM; DYSTONIA; HEART MUSCLE ISCHEMIA; HUMAN; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; MIGRAINE; NEURAL TUBE DEFECT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION; TARDIVE DYSKINESIA;

ADRENERGIC ALPHA-ANTAGONISTS; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM CHANNEL BLOCKERS; ERGOTAMINES; FEMALE; HUMAN; MIGRAINE; RECEPTORS, SEROTONIN; SUMATRIPTAN;

EID: 0027361402     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199311113292008     Document Type: Review

References (107)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8: Suppl 7: 1-96
2. Olesen J, Larsen B, Lauritzen M Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981; 9: 344-352
3. Barkley GL, Tepley N, Simkins RT, Moran JE, Welch KMA Neuromagnetic fields in migraine: preliminary findings. Cephalalgia 1990; 10: 171-176
4. Leao AAP Spreading depression of activity in cerebral cortex. J Neurophysiol 1944; 7: 359-390
5. Skyhoj-Olsen T, Friberg L, Lassen NA Ischemia may be the primary cause of the neurologic deficits in classic migraine. Arch Neurol 1987; 44: 156-161
6. Moskowitz MA The neurobiology of vascular head pain. Ann Neurol 1984; 16: 157-168
7. Welch KMA Migraine: a biobehavioral disorder. Arch Neurol 1987; 44: 323-327
8. Gauthier J, Bois R, Allaire D, Drolet M Evaluation of skin temperature biofeedback training at two different sites for migraine. J Behav Med 1981; 4: 407-419
9. International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine: first edition. Cephalalgia 1991; 11: 1-12
10. Tfelt-Hansen P, Olesen J Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia 1984; 4: 107-111
11. Peatfield RC, Petty RG, Rose FC Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine. Cephalalgia 1983; 3: 129-134
12. Hakkarainen H, Gustafsson B, Stockman O A comparative trial of ergotamine tartrate, acetysalicylic acid and a dextropropoxyphene compound in acute migraine attacks. Headache 1978; 18: 35-39
13. Somerville BW Treatment of migraine attacks with an analgesic combination (Mersyndol). Med J Aust 1976; 1: 865-866
14. Hakkarainen H, Quiding H, Stockman O Mild analgesics as an alternative to ergotamine in migraine: a comparative trial with acetylsalicylic acid, ergotamine tartrate, and dextropropoxyphene compound. J Clin Pharmacol 1989; 20: 590-595
15. Johnson ES, Ratcliffe DM, Wilkinson M Naproxen sodium in the treatment of migraine. Cephalalgia 1985; 5: 5-10
16. Pradalier A, Rancurel G, Dordain S, Verdure L, Rascol A, Dry J Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compound. Cephalalgia 1985; 5: 107-113
17. Nestvold K, Kloster R, Partinen M, Sulkava R Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia 1985; 5: 115-119
18. Larsen BH, Christiansen LV, Andersen B, Oleson J Randomized double-blind comparison of tolfenamic acid and paracetamol in migraine. Acta Neurol Scand 1990; 81: 464-467
19. Carasso RL, Peled O, Yehuda S Flufenamic acid in prostaglandin migraine. Int J Neurosci 1985; 27: 67-71
20. Awidi AS Efficacy of flurbiprofen in the treatment of acute migraine attacks: a double-blind cross-over study. Curr Ther Res 1982; 32: 492-497
21. Karachalios GN, Fotiadou A, Chrisikos N, Karabetsos A, Kehagioglou K Treatment of acute migraine attack with diclofenac sodium: a double-blind study. Headache 1992; 32: 98-100
22. Kloster R, Nestvold K, Vilming ST A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia 1992; 12: 169-171
23. Klapper JA, Stanton JS Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches. Headache 1991; 31: 523-524
24. Selby G, Lance JW Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 1960; 23: 23-32
25. Schmidt R, Fanchamps A Effect of caffeine on intestinal absorption of ergotamine in man. Eur J Clin Pharmacol 1974; 7: 213-216
26. Hakkarainen H, Allonen H Ergotamine vs. metoclopramide vs. their combination in acute migraine attacks. Headache 1982; 22: 10-12
27. Callaham M, Raskin N A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986; 26: 168-171
28. Saadah HA Abortive headache therapy in the office with intravenous dihydroergotamine in the treatment of acute migraine headache. Headache 1992; 32: 143-146
29. Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology 1989; 39: 590-592
30. Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991; 325: 316-321
31. Sumatriptan Auto-Injector Study Group. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. Eur Neurol 1991; 31: 323-331
32. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H Jr Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991; 265: 2831-2835
33. Oral Sumatriptan International Multiple-Dose Study Group. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol 1991; 31: 306-313
34. Anderson BA. Optimizing the dosage regimen for oral sumatriptan -- clinical results. In: Clifford-Rose F, ed. New advances in headache research. Vol. 3. London: Smith Gordon (in press).
35. Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol 1991; 31: 314-322
36. Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol 1992; 32: 177-184
37. Tek DS, McClellan DS, Olshaker JS, Allen CL, Arthur DC A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med 1990; 19: 1083-1087
38. Lane PL, McLellan BA, Baggoley CJ Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med 1989; 18: 360-365
39. Jones S, Sklar D, Dougherty J, White W Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA 1989; 261: 1174-1176
40. Rapoport A, Weeks R, Sheftell F, Analgesic rebound headache: theoretical and practical implications. Cephalalgia 1985; 5: Suppl 3: 448-449
41. Noda S, Umezaki H, Fukuda Y Response of common migraine and cluster headache attacks to intravenous injection of aspirin. Neurol Med 1984; 21: 333-334
42. Buzzi MG, Sakas DE, Moskowitz MA Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater. Eur J Pharmacol 1989; 65: 251-258
43. Bennett A Prostaglandins: their release, biological effects and relationships to pain and inflammation. Cephalalgia 1986; 6: Suppl 4: 17-20
44. Pradalier A, Vincent D Migraine et anti-inflammatoires non-steroidiens. Pathol Biol (Paris) 1992; 40: 397-405
45. Tansey MJB. The long term safety of sumatriptan. In: Clifford-Rose F, ed. New advances in headache research. Vol. 3. London: Smith Gordon (in press).
46. Dechant KL, Clissold SP Sumatriptan: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1992; 43: 776-798
47. Stricker BHC Coronary vasospasm and sumatriptan. BMJ 1992; 305: 118-118
48. Abrahamsen B, Christiansen BD Angina pectoris after sumatriptan (Imigran). Ugeskr Laeger 1992; 154: 3602-3603
49. Curtin T, Brooks AP, Roberts JA Cardiorespiratory distress after sumatriptan given by injection. BMJ 1992; 305: 713-714
50. Willett F, Curzen N, Adams J, Armitage M Coronary vasospasm induced by subcutaneous sumatriptan. BMJ 1992; 304: 1415-1415
51. Ottervanger JP, Paalman HJA, Boxma GL, Stricker BHC Transmural myocardial infarction after sumatriptan. Lancet 1993; 341: 861-862
52. Chester AH, Martin GR, Bodelsson M, 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res 1990; 24: 932-937
53. MacIntyre PD, Bhargava B, Hogg KJ, Gemmill JD, Hillis WS Effect of subcutaneous sumatriptan, a selective 5HT, agonist, on the systemic, pulmonary, and coronary circulation. Circulation 1993; 87: 401-405
54. Lloyd DK, Pilgrim AJ, Simmons VE Coronary vasospasm and sumatriptan. BMJ 1992; 305: 310-311
55. Saxena PR, Ferrari MD From serotonin receptor classification to the antimigraine drug sumatriptan. Cephalalgia 1992; 2: 187-196
56. Moskowitz MA, Buzzi MG Neuroeffector functions of sensory fibers: implications for headache mechanisms and drug actions. J Neurol 1991; 238: Suppl 1: S18-S22
57. Goadsby PJ, Edvinsson L, Ekman R Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988; 23: 193-196
58. Goadsby PJ, Edvinsson L Sumatriptan reverses the changes in calcitonin gene-related peptide seen in the headache phase of migraine. Cephalalgia 1991; 11: Suppl 11: 3-4
59. Spierings ELH, Saxena PR Antimigraine drugs and cranial arteriovenous shunting in the cat. Neurology 1980; 30: 696-701
60. Bell R, Montoya D, Shuaib A, Lee MA A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med 1990; 19: 1079-1082
61. Raskin NH Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986; 36: 995-997
62. Basbaum AI, Fields HL Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984; 7: 309-338
63. Lance JW, Curran DA, Anthony M Investigations into the mechanism and treatment of chronic headache. Med J Aust 1965; 2: 909-914
64. Drummond PD Effectiveness of methysergide in relation to clinical features of migraine. Headache 1985; 25: 145-146
65. Couch JR, Hassanein RS Amitriptyline in migraine prophylaxis. Arch Neurol 1979; 36: 695-699
66. Couch JR, Ziegler DK, Hassanein RS Evaluation of the relationship between migraine headache and depression. Headache 1975; 15: 41-50
67. Anthony M, Lance JW Monoamine oxidase inhibition in the treatment of migraine. Arch Neurol 1969; 21: 263-268
68. Weber RB, Reinmuth OM The treatment of migraine with propranolol. Neurology 1972; 22: 366-369
69. Wideroe TE, Vigander T Propranolol in the treatment of migraine. BMJ 1974; 2: 699-701
70. Kuritzky A, Hering R Prophylactic treatment of migraine with long acting propranolol -- a comparison with placebo. Cephalalgia 1987; 7: Suppl 6: 457-458 abstract.
71. Kangasniemi P, Andersen AR, Andersson PG, Classic migraine: effective prophylaxis with metoprolol. Cephalalgia 1987; 7: Suppl 6: 464-464 abstract.
72. Stensrud P, Sjaastad O Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache 1980; 20: 204-207
73. Johansson V Atenolol in migraine prophylaxis: a double-blind crossover multicenter study. Headache 1987; 27: 372-374
74. Hakkarainen H, Kangasniemi P. Timolol maleate in the prophylactic treatment of classic and common migraine. In: Proceedings of the Timolol Intercontinental Symposium, Stockholm, October 27-28, 1981. New York: Biomedical Information Corp., 1982:433-44.
75. Ryan RE Sr, Ryan RE Jr, Sudilovsky A Nadolol: its use in the prophylactic treatment of migraine. Headache 1983; 23: 26-31
76. Albers GW, Simon LT, Hamik A, Peroutka SJ Nifedipine versus propranolol for the initial prophylaxis in migraine. Headache 1989; 29: 215-218
77. McArthur JC, Marek K, Pestronk A, McArthur J, Peroutka SJ Nifedipine in the prophylaxis of classic migraine: a crossover, double-masked, placebo-controlled study of headache frequency and side effects. Neurology 1989; 39: 284-286
78. Gelmers HJ Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine. Headache 1983; 23: 106-109
79. Havanka-Kanniainen H, Hokkanen E, Myllyla VV Efficacy of nimodipine in the prophylaxis of migraine. Cephalalgia 1985; 5: 39-43
80. Meyer JS, Hardenberg J Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache 1983; 23: 266-277
81. Stewart DJ, Gelston A, Hakim A Effect of prophylactic administration of nimodipine in patients with migraine. Headache 1988; 28: 260-262
82. Solomon GD, Steel JG, Spaccavento LJ Verapamil prophylaxis of migraine: a double-blind, placebo-controlled study. JAMA 1983; 250: 2500-2502
83. Markley HG, Cheronis JCD, Piepho RW Verapamil in prophylactic therapy of migraine. Neurology 1984; 34: 973-976
84. Markley HG Verapamil and migraine prophylaxis: mechanisms and efficacy. Am J Med 1991; 90: Suppl 5A: 5A-48S
85. Stensrud P, Sjaastad O Clinical trial of a new anti-bradykinin, anti-inflammatory drug, ketoprofen (19.583 r.p.) in migraine prophylaxis. Headache 1974; 14: 96-100
86. Mikkelsen BM, Falk JV Prophylactic treatment of migraine and tolfenamic acid: a comparative double-blind crossover study between tolfenamic acid and placebo. Acta Neurol Scand 1982; 66: 105-111
87. Johnson RH, Hornabrook RW, Lambie DG Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis. Acta Neurol Scand 1986; 73: 490-492
88. Welch KMA, Ellis DJ, Keenan PA Successful migraine prophylaxis with naproxen sodium. Neurology 1985; 35: 1304-1310
89. Masel BE, Chesson AL, Alperin JB, Levin HS, Peters BH Clinical trial of platelet inhibition, using aspirin and dipyridamole in migraine prophylaxis. Neurology 1978; 28: 371-371 abstract.
90. Buring JE, Peto R, Hennekens CH Low-dose aspirin for migraine prophylaxis. JAMA 1990; 264: 1711-1713
91. Sorensen KV Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand 1988; 78: 346-348
92. Hering R, Kuritzky A Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 1992; 12: 81-84
93. Peroutka SJ Developments in 5-hydroxytryptamine receptor pharmacology in migraine. Neurol Clin 1990; 8: 829-839
94. Mylecharane EJ 5-HT receptor antagonists and migraine therapy. J Neurol 1991; 238: Suppl 1: S45-S52
95. Shanks RG. Mechanisms of action of beta-adrenoceptor antagonists in migraine. In: Carroll JD, Pfaffenrath V, Sjaastad O, eds. Migraine and beta-blockade. Molndal, Sweden: A.B. Hassle, 1985:45-54.
96. Schoenen J, Timsit-Berthier M, Timsit M Correlations between contingent negative variation and plasma levels of catecholamines in headache patients. Cephalalgia 1985; 5: Suppl 3: 480-480 abstract.
97. Schoenen J, Maertens de Hoordhout A, Timsit-Berthier M, Timsit M Contingent negative variation and efficacy of beta-blocking agents in migraine. Cephalalgia 1986; 6: 229-233
98. Greenberg DA Calcium channel antagonists and the treatment of migraine. Clin Neuropharmacol 1986; 9: 311-328
99. Sargent J, Solbach P, Damasio H, A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache 1985; 25: 320-324
100. Welch KMA, D'Andrea G, Tepley N, Barkley G, Ramadan NM The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin 1990; 8: 817-828
101. de Lignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG Prevention of menstrual migraine by percutaneous oestradiol. BMJ 1986; 293: 1540-1540
102. Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988; 2: 113-120
103. Welch KMA, Darnley D, Simkins RT The role of estrogen in migraine: a review and hypothesis. Cephalalgia 1984; 4: 227-236
104. Sarno AP Jr, Miller EJ Jr, Lundblad EG Premenstrual syndrome: beneficial effects of periodic, low-dose danazol. Obstet Gynecol 1987; 70: 33-36
105. Powles TJ Prevention of migrainous headaches by tamoxifen. Lancet 1986; 2: 1344-1344
106. Andersen AN, Larsen JF, Steenstrup OR, Svendstrup B, Nielsen J Effect of bromocriptine on the premenstrual syndrome: a double-blind clinical trial. Br J Obstet Gynaecol 1977; 84: 370-374
107. Somerville BW Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 1975; 25: 239-244